ADVANCE · Advance Agrolife Ltd · Chemical Manufacturing
Last close, 30 Oct
24.6% below 52-week high
52-week range: as of 30 Oct 2026.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Stock Condition as of 30 Oct 2026 close
Full signal detail →Chart
Fundamentals as of 15 Sep 2026 · the company's own latest record is 47 days old
Revenue (latest Q)
₹330 Cr
Revenue YoY
PAT YoY
+152.2%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
2.4
P/S (TTM)
1
Sector P/E
20.6
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| ADVANCE (this stock) | 10.2 | 2.4 | +6.1% | +15.8% | 0.32 | 0.0% |
| Asian Paints | 53 | 11.1 | +12.8% | +22.3% | 0.18 | +1.1% |
| Solar Industries India | 99.6 | 26.6 | +17.6% | +31.4% | 13.68 | +0.1% |
| Pidilite Industries | 61.3 | 19.4 | +17.2% | +24.4% | 0.04 | +0.7% |
Promoter
stable
FII
rising 1q
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| canonicalSymbol | date | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| ADVANCE | 2026-10-21 | 795817 | 2 | STRONG | BULK |
| ADVANCE | 2026-10-15 | 913618 | 2 | WEAK | BULK |
| ADVANCE | 2026-10-14 | 974094 | 2 | WEAK | BULK |
| ADVANCE | 2026-10-13 | 2653384 | 5 | WEAK | BULK |
| ADVANCE | 2026-10-02 | 350000 | 1 | WEAK | BULK |
| ADVANCE | 2026-10-01 | 350000 | 1 | WEAK | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: Advance Agrolife Limited (AAL) presented its investor presentation on the unaudited financial results for the quarter ended June 30, 2026. The document highlighted AAL's 20-year legacy as a research-driven agrochemical manufacturer with an installed capacity of nearly 90,000 MTPA. The company reported a significant increase in revenue, with Q1 FY27 revenue from operations reaching ₹3304 million, a 96% year-on-year increase. EBITDA for the same period was ₹351 million, reflecting a 105% year-on-year growth. Management noted that the company aims to increase its export revenue share from 2% to 20% by FY29. The presentation also detailed AAL's strategic focus on backward integration and specialized formulations to enhance margins and reduce costs. Additionally, the company is expanding its manufacturing capabilities with new facilities in Gidani and Dahej. Overall, the presentation emphasized AAL's strong operational foundation and growth strategy.
Management highlighted significant revenue growth and strategic expansions.
Sourced from an exchange-filed presentation, dated 06 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Advance Agrolife Limited (AAL) presented its audited financial results for the year ended March 31, 2026, highlighting a total revenue of ₹6,417.5 million, a 28% increase from the previous year. The EBITDA for FY26 was reported at ₹636.9 million, with a margin of 9.99%, reflecting a 50 basis points improvement. The company emphasized its strategic shift towards backward integration, which aims to enhance margins by manufacturing technical grades in-house. AAL also reported a significant increase in PAT for Q4 FY26, reaching ₹74.61 million, up 422% year-on-year. The presentation outlined plans to expand export revenue from 2% to 20% by FY29 and to enhance production capabilities with new facilities. Additionally, AAL is committed to sustainable practices, including the implementation of a solar power plant. The company’s shareholding structure as of March 31, 2026, indicated a market cap of ₹5,467.5 million.
The presentation highlighted strong financial growth and strategic initiatives.
Sourced from an exchange-filed presentation, dated 08 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Advance Agrolife Limited's investor presentation detailed the company's growth trajectory and operational strategies. The company reported a total income of ₹1,338 million for Q3 FY26, marking an 18% year-on-year increase, and a 25% increase for the nine months ended December 31, 2025, totaling ₹5,153.9 million. EBITDA for Q3 FY26 was ₹73.5 million, with a margin of 5.5%. The presentation highlighted the company's backward integration strategy, transitioning from a formulator to a technical manufacturer, which aims to enhance margins by reducing reliance on external sourcing. Advance Agrolife also plans to increase its export revenue share from 2% to 20% by FY29. The company is expanding its manufacturing capabilities, including a new R&D laboratory and a solar power plant, to support sustainable practices. The presentation emphasized a strong client retention rate and a diversified product portfolio across various agrochemical segments.
The presentation highlighted significant growth and strategic initiatives aimed at enhancing operational efficiency and market presence.
Sourced from an exchange-filed presentation, dated 07 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedAdvance Agrolife Limited's FY2025-26 annual report highlights its strategic focus on backward integration, capacity expansion, and operational excellence, supported by a successful IPO that strengthened its capital base. The company has diversified its product portfolio across insecticides, fungicides, herbicides, and plant growth regulators, enhancing its market reach and resilience. It has initiated captive production of Pretilachlor Technical and PEDA, reducing import dependence and improving supply chain resilience. The report also emphasizes the company's commitment to sustainability through a 3.75 MW solar power project and its expansion plans, including a new facility in Gujarat. The company operates in a dynamic environment with global and Indian agrochemical industry growth prospects, though it faces challenges like regulatory delays and global competition.
- Strategic focus on backward integration and capacity expansion to enhance self-reliance and value capture.
- Diversified product portfolio across multiple agrochemical segments to reduce concentration risk and expand market reach.
- Initiated captive production of Pretilachlor Technical and PEDA to strengthen backward integration and reduce import dependence.
- Commitment to sustainability through renewable energy initiatives and integrated pest management practices.
- Expansion plans including a new manufacturing facility in Gujarat to support long-term growth and operational efficiency.
Key takeaway: Advance Agrolife Limited is strategically expanding its integrated manufacturing capabilities and product portfolio to enhance self-reliance, sustainability, and market resilience in the growing agrochemical industry.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Regulatory Action (2 items)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Regulatory Action
2 occurrencesRecent (last 12 months)
The company has not spent the mandated Corporate Social Responsibility (CSR) amounts for FY 2020–21 to FY 2023–24, with a total potential liability of ₨1,25,67,468 if penalties are imposed by authorities.
The company has not spent the mandated Corporate Social Responsibility (CSR) amounts for FY 2020–21 to FY 2023–24, with a total potential liability of ₨1,25,67,468 if penalties are imposed by authorities.
Routine disclosures
Contingent Liability
2 occurrencesRecent (last 12 months)
The company has disclosed pending litigations impacting its financial position, referenced in Note 40 on Contingent Liabilities.
The company has disclosed pending litigations impacting its financial position, referenced in Note 40 on Contingent Liabilities.
Related-Party Transaction
2 occurrencesRecent (last 12 months)
The company has transactions with related parties including relatives of KMPs and a trust where KMPs are trustees, involving remuneration, sale of goods, royalty, purchases, and CSR expenditures.
The company has transactions with related parties including relatives of KMPs and a trust where KMPs are trustees, involving remuneration, sale of goods, royalty, purchases, and CSR expenditures.